China explores new mode of pharmaceutical R&D
Clinical Trials | News | 0 Comment | 03 May, 2021
Guangzhou Link Health Pharma Co., Ltd. (Link Health), based in China, and Australian firm George Clinical Pty Ltd (Georg...Read more
Fujifilm initiates new Ph III trial of Avigan for COVID-19 treatment in Japan
Clinical Trials | News | 0 Comment | 21 Apr, 2021
FUJIFILM Toyama Chemical has announced the initiation of a new phase III clinical trial in Japan concerning its anti-inf...Read more
TrialWire launches StudyBoost, the Clinical trial insurance plan
Clinical Trials | News | 1 Comment | 23 Mar, 2021
TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost...Read more
UK conducts innovative COVID-19 trials with deliberate volunteered infection
Clinical Trials | News | 0 Comment | 02 Mar, 2021
United Kingdom government announced an investment of 33.6 million pounds ($43.5 million) in a study called “h...Read more
Panthera to evaluate AstraZeneca’s AZD7442 for the potential prevention of COVID-19
Clinical Trials | News | 0 Comment | 30 Dec, 2020
Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase...Read more
Tychan to begin Ph 3 trial for mAb TY027 against COVID-19
Clinical Trials | News | 0 Comment | 14 Dec, 2020
In June 2020, Tychan began its Phase 1 clinical safety trials in humans to evaluate TY027, a monoclonal antibo...Read more
Contract for innovative delivery system for COVID-19 vaccine
Clinical Trials | News | 0 Comment | 16 Nov, 2020
Croda International Plc (“Croda” or “the Group”), the speciality chemical company that uses smar...Read more
CEPI funds Sichuan Clover for COVID-19 vaccine development
Clinical Trials | News | 0 Comment | 05 Nov, 2020
CEPI, the Coalition for Epidemic Preparedness Innovations, based in Norway, has announced that it will fund the developm...Read more
Russia- Destination of choice for Asian pharma companies
Clinical Trials | Opinion | 0 Comment | 03 Nov, 2020
Asian biotech industry has been experiencing an escalating boom over the past several years. Pharmaceutical companies ha...Read more
Daewoong pharma partners with Tufts medical center for Ph 2 trial with Niclosamide
Clinical Trials | News | 0 Comment | 30 Oct, 2020
Daewoong Pharmaceutical announced on 26 Oct 2020 that the collaborative clinical research agreement betwe...Read more
Asieris announces approval for Ph 1 trial of bladder cancer drug in Australia
Clinical Trials | News | 0 Comment | 29 Oct, 2020
Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new...Read more
APRINOIA announces NMPA approval to initiate Ph 3 clinical trial
Clinical Trials | News | 0 Comment | 28 Oct, 2020
APRINOIA Therapeutics advancing a pipeline featuring diagnostic and therapeutic programs, collectively targeting brain d...Read more
Evado is pleased to announce the launch of Evado OnDemand.
Clinical Trials | News | 1 Comment | 26 Oct, 2020
The COVID Pandemic has dramatically disrupted the delivery of clinical trials. Sponsors now require instant access...Read more
Oric Pharma teams up with Korean firm to expand precision oncology pipeline
Clinical Trials | News | 0 Comment | 23 Oct, 2020
ORIC Pharmaceuticals, Inc., a clinical-stage oncology company focused on developing treatments that address mechanisms o...Read more
Astellas to present new roxadustat data in anemia of CKD at ASN kidney week
Clinical Trials | News | 0 Comment | 19 Oct, 2020
Japan-based Astellas Pharma Inc. (Astellas) has announced that in collaboration with FibroGen and AstraZeneca, 42 roxadu...Read more
Astellas, Seagen announce positive results in Ph 2 pivotal trial of PADCEV
Clinical Trials | News | 0 Comment | 14 Oct, 2020
Japan-based Astellas Pharma Inc. and Seagen Inc. in the US have announced positive topline results from the second cohor...Read more
MVC obtains Taiwan government subsidy for initiating Ph 1 trial of COVID-19 vaccine
Clinical Trials | News | 0 Comment | 13 Oct, 2020
Taiwan based Medigen Vaccine Biologics Corporation (MVC), a biopharmaceutical company focusing on the development a...Read more
MedAlliance enrolls first two patients in PRISTINE study
Clinical Trials | News | 0 Comment | 12 Oct, 2020
MedAlliance a privately-owned medical technology company, headquartered in Nyon, Switzerland has announced the enrolment...Read more